Adma Biologics reported $32.34M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Adma Biologics ADMA:US $ 32.34M 14.15M
Agile Therapeutics AGRX:US $ 9.57M 2.07M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
China Cord Blood CO:US 650.78M 6.22M
Dynavax Technologies DVAX:US $ 528.93M 324.29M
Kindred Biosciences KIN:US $ 11.26M 4.71M
Minerva Neurosciences NERV:US $ 3.08M 1.36M
Novavax NVAX:US $ 1753.42M 101.9M
Omeros OMER:US $ 42.82M 4.88M
Takeda 4502:JP Y 1918750M 273984M